An inhibitor of breast cancer stem cells
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ML-239

Item No. 15188

Technical Information
Formal Name
2-(2,4,6-trichlorophenoxy)-acetic acid, (2E)-2-(1H-pyrrol-2-ylmethylene)hydrazide
CAS Number
1378872-36-6
Synonyms
  • CID-49843203
Molecular Formula
C13H10Cl3N3O2
Formula Weight
Purity
≥98%
A crystalline solid
DMSO: 10 mg/ml
λmax
314 nm
SMILES
O=C(COC1=C(Cl)C=C(Cl)C=C1Cl)N/N=C/C2=CC=CN2
InChi Code
InChI=1S/C13H10Cl3N3O2/c14-8-4-10(15)13(11(16)5-8)21-7-12(20)19-18-6-9-2-1-3-17-9/h1-6,17H,7H2,(H,19,20)/b18-6+
InChi Key
NVEDPFICKAIHKD-NGYBGAFCSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    ML-239 is an inhibitor of cancer stem cells, displaying greater than 23-fold selective inhibition of a breast cancer stem cell-like cell line (EC50 = 1.18 µM) over an isogenic control cell line (EC50 = 27.6 µM).1,2,3 It is also toxic to the breast carcinoma cell line MDA-MB-231.1 ML-239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cytokine pathways.1,3 It is stable in saline and modestly stable in human plasma.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Carmody, L.C., Germain, A.R., VerPlank, L., et alPhenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells. J. Biomol. Screen. 17(9), 1204-1210 (2012).

    2. Germain, A.R., Carmody, L.C., Morgan, B., et alIdentification of a selective small molecule inhibitor of breast cancer stem cells. Bioorg. Med. Chem. Lett. 22(10), 3571-3574 (2012).

    3. Carmody, L., Garmain, A., Morgan, B., et alIdentification of a selective small-molecule inhibitor of breast cancer stem cells - Probe 1. 1, 1-13 (2011).